Abstract: The present invention is directed toward pharmaceutical compositions comprising an isolated polypeptide and a pharmaceutically acceptable carrier. The present invention also discloses an antibody or an antigen-binding portion thereof that bind to the isolated polypeptide. Methods of inhibiting cancer cells growth are also disclosed, comprising administering the isolated polypeptide or the antibody described herein to a subject in need thereof.
Type:
Grant
Filed:
July 30, 2015
Date of Patent:
August 8, 2017
Assignee:
Chang Gung Memorial Hospital, Linkou Branch
Abstract: The present invention is directed toward pharmaceutical compositions comprising an isolated polypeptide and a pharmaceutically acceptable carrier. The present invention also discloses an antibody or an antigen-binding portion thereof that bind to the isolated polypeptide. Methods of inhibiting cancer cells growth are also disclosed, comprising administering the isolated polypeptide or the antibody described herein to a subject in need thereof.
Type:
Grant
Filed:
February 4, 2014
Date of Patent:
September 29, 2015
Assignee:
CHANG GUNG MEMORIAL HOSPITAL, LINKOU BRANCH
Abstract: The present invention is directed toward pharmaceutical compositions comprising an isolated polypeptide and a pharmaceutically acceptable carrier. The present invention also discloses an antibody or an antigen-binding portion thereof that bind to the isolated polypeptide. Methods of inhibiting cancer cells growth are also disclosed, comprising administering the isolated polypeptide or the antibody described herein to a subject in need thereof.
Type:
Application
Filed:
February 4, 2014
Publication date:
August 7, 2014
Applicant:
Chang Gung Memorial Hospital, Linkou Branch